Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

471
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
471
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

341
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
341
Hazard Ratio01:12

Hazard Ratio

274
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
274

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unmasking Evans Syndrome: A Case of New Onset Anemia and Thrombocytopenia in a Pregnant Patient With Systemic Lupus Erythematosus.

Case reports in hematology·2026
Same author

Changes in retroperitoneal anatomy of the lumbar spine in supine, prone, and lateral lumbar spine MRIs.

Spine deformity·2026
Same author

Use of Zone 1 REBOA in Deployed U.S. Military Settings Is Associated With Improved Survival to Next Role of Care.

Military medicine·2026
Same author

The Use of Fam-Trastuzumab Deruxtecan-nxki in Treating ERBB2 Amplified Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer: A Case Report.

Case reports in oncological medicine·2026
Same author

The Effects of Military Occupation on Semen Analysis.

Cureus·2026
Same author

Seraph-100 Microbind Affinity Blood Filter Flow Driven by the Extracorporeal Membrane Oxygenation Circuit in Extracorporeal Membrane Oxygenation Patients.

Blood purification·2026

Related Experiment Video

Updated: Sep 25, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

398

Use of a Chemotherapy Toxicity Prediction Tool to Decrease Risks for Hospitalization in Older Patients.

Mintcho E Mintchev1, Arjun G Kalra2, Chung-Ting J Kou1

  • 1Hematology and Oncology Service, Brooke Army Medical Center, Fort Sam Houston, USA.

Cureus
|May 2, 2022
PubMed
Summary
This summary is machine-generated.

The Cancer and Aging Research Group (CARG) toxicity score helps identify older cancer patients who are fit for chemotherapy. Using CARG reduced hospital admissions and emergency visits, suggesting a safer approach to cancer care.

Keywords:
chemotherapy-related toxicityeastern cooperative oncology group (ecog)geriatric assessmentgeriatric oncologymedical frailtymilitary medicineolder adultquality improvement researchrisks for hospitalizationtreatment decisions

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.3K

Related Experiment Videos

Last Updated: Sep 25, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

398
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.6K
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.3K

Area of Science:

  • Geriatric Oncology
  • Clinical Pharmacology
  • Cancer Treatment

Background:

  • Traditional performance status (PS) scales like ECOG and Karnofsky have limitations in predicting outcomes and adverse events in elderly cancer patients.
  • Older adults with cancer often require tailored treatment strategies to optimize outcomes and minimize toxicity.

Purpose of the Study:

  • To evaluate the utility of the Cancer and Aging Research Group (CARG) toxicity prediction score in managing older cancer patients.
  • To assess the impact of CARG score adoption on clinical decision-making, hospital admissions, and emergency department (ED) visits.

Main Methods:

  • Retrospective review of patients aged 75 and older receiving systemic therapy.
  • Comparison of CARG score utilization and patient outcomes before and after its institutional adoption.
  • Analysis of inpatient admissions, ED visits, and medical management based on CARG-modified treatment plans.

Main Results:

  • CARG documentation increased from 12.5% to 41% after adoption, though physician reliance posed a limitation.
  • Patients whose treatment was modified based on CARG had significantly fewer mean inpatient admissions (0.7 vs. 2.3) and ED visits (1.1 vs. 2.5).
  • Mean inpatient admission days also decreased (4.3 vs. 8) when CARG influenced management.

Conclusions:

  • The CARG score offers a more personalized and potentially safer approach to cancer treatment in older adults compared to conventional PS scales.
  • Integrating CARG into patient screening could enhance its application and its predictive capacity for reducing hospitalization risks in elderly cancer patients.